A Phase 2 Study of Albuferon in Combination with Ribavirin in non-responders to proir interferon therapy for chronic Hepatitis C

Conference Reports for NATAP

AASLD
American Association For The Study of Liver Diseases
November 11-15, 2005 San Francisco


A Phase 2 Study of Albuferon in Combination with Ribavirin in non-responders to proir interferon therapy for chronic Hepatitis C

	AASLD Nov 15, 2005 San Francisco Reported by Jules Levin